A groundbreaking study identifies MYSM1 as a critical regulator of lung adenocarcinoma progression. The protein drives cancer growth through previously unknown molecular mechanisms involving key signaling pathways.
Groundbreaking research using CRISPR/Cas9 reveals how the TBPL1 transcription factor creates unique molecular signatures across different breast cancer cell lines. The findings explain why treatments fail and point to personalized approaches.
The Scaffolding Revolution in Cellular Agriculture The race to perfect cultured meat production has intensified focus on one critical component:…
